Literature DB >> 8923370

Arthroscopic lavage treatment in rheumatoid arthritis of the knee.

A Sharma1, B A Baethge, J C Acebes, J R Lisse.   

Abstract

OBJECTIVE: To assess the efficacy of outpatient arthroscopic lavage in rheumatoid arthritis (RA) of the knee.
METHODS: 9 patients with RA and active synovitis of at least one knee were selected. All patients were taking disease modifying antirheumatic drugs and nonsteroidal antiinflammatory drugs and had failed intraarticular corticosteroid injection of the knee. Using the 1.9 mm office arthroscope and strict sterile technique the affected knee was lavaged with at least 750 cc of normal saline. At the end of the procedure 40 mg triamcinolone acetonide was injected through the arthroscope. Assessment was done at baseline and 4, 8, and 12 weeks after the lavage using a visual analog scale for pain and 50 foot walk time.
RESULTS: 8 of the 9 patients showed marked improvement in their pain and walk time. This effect was maintained at least 12 weeks after the procedure.
CONCLUSION: Office arthroscopic lavage treatment is beneficial in a selected group of patients. This procedure is simple and well tolerated without major complications, and may be an option when more conservative therapies have failed.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8923370

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  3 in total

Review 1.  A risk-benefit assessment of intra-articular corticosteroids in rheumatic disorders.

Authors:  J A Hunter; T H Blyth
Journal:  Drug Saf       Date:  1999-11       Impact factor: 5.606

2.  Treatment for chronic synovitis of knee: arthroscopic or open synovectomy.

Authors:  Xiaoyun Pan; Xianlong Zhang; Zhongtang Liu; Hong Wen; Xin Mao
Journal:  Rheumatol Int       Date:  2011-03-25       Impact factor: 2.631

3.  Volume of a wash and the other conditions for maximum therapeutic effect of arthroscopic lavage in rheumatoid knees.

Authors:  Nobuyuki Tanaka; Hisashi Sakahashi; Kazuya Hirose; Takumi Ishima; Seiichi Ishii
Journal:  Clin Rheumatol       Date:  2005-10-19       Impact factor: 2.980

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.